Docstoc

for Psoriasis and Vitiligo

Document Sample
for Psoriasis and Vitiligo Powered By Docstoc
					The EX-308 handpiece features a continuously adjustable spot size from 18 mm2 to 2 mm
round, with constant fluence. Operators can adjust the size and shape of the beam, even
while dosing, and deliver a consistent dose. Arms, legs, and back are quickly treated
with the largest spot size, while the small 2 mm spot allows precision treatments of
the face, neck, and scalp.

A brightly lit aiming beam corresponds to the size and shape of the dose-delivery
beam for easy, accurate, and rapid targeted treatments.



                                                                                                                                                    for Psoriasis and Vitiligo
The dose-delivery beam has a flat-top profile for uniform dosing and clearance.
Collimation eliminates surface scatter and facilitates therapeutic penetration
of the 308-nm for maximum clinical efficacy.

Weighing about 100 lbs, the EX-308 is small enough for any treatment room
and is easily portable.




Wavelength                           308nm ± 1nm
Max Pulse Repetition Rate            150Hz
Max Output Power                     2.25W

Delivery                             1.5m Liquid Filled Fiber Optic
Fiber Life                           25 Million Shots, User Replaceable
Beam Size                            Continuously Adjustable from 18 mm2 to 2 mm
Operating Modes                      Intermittent, Continuous, Custom

Electrical Inputs                    115VAC, 6A, 47Hz to 63Hz
                                     230VAC, 3A, 47Hz to 63Hz
Gas                                  XeHCl Mix
Gas Life                             Approximately 1 Year
Mirror Life                          25 Million Shots

Weight                               48kg (106 lbs)
Size                                 36cm Wide x 68cm Long x 82cm tall
                                     (14" x 27" x 32")
Warranty                             1 year




                                                                                                                                                       UVB Laser Phototherapy. Advanced




2380-G Camino Vida Roble
Carlsbad, CA 92011                                                                  EX-308 manufactured and distributed under license from
United States                                                                       SurgiLight, Inc. Federal law restricts this device to sale by
Phone:+1 760 804 1648                                                               or on the order of a physician. Product specifications are
Fax: +1 760 804 1657                              15 mJ, 20-35 nS, 150 Hz, 308 nm   subject to change without notice. © 2005 Ra Medical
www.ramed.com                                                                       Systems, Inc. All rights reserved.
                                    The EX-308 safely delivers precisely targeted, high-dose 308-nm UVB             Therapy with the EX-308 is widely reimbursed under laser-specific
                                    to lesions without exposing healthy skin. Patients enjoy fast clearing          codes at about three to four times the standard phototherapy rates.
                                    and long remissions after 6 to 10 treatments for psoriasis and about            Carriers including Aetna; Cigna; UnitedHealthcare; the Blue Cross
                                    25 sessions for vitiligo.                                                       Blue Shield Plans of WellPoint, Carefirst, Regence, Empire, and
                                    Treatments take only a few minutes twice each week. Typical psoriasis           Independence; and Medicare have published policies approving
                                    remission is 4 to 6 months.                                                     excimer laser treatment for psoriasis.

                                    Positive outcomes after very few treatments encourage patient                   As most treatment regimens consist of about 10 to 25 treatments,
                                    compliance and enhance satisfaction.                                            depending on the condition, the EX-308 generates recurring revenue
                                    Clinical studies have shown:                                                    for your practice.
                                        • 84% of psoriasis patients have 75% clearing in 6 to                       The EX-308 is both affordable and profitable for your practice. There is
                                           10 sessions.1
                                                                                                                    no fee-for-service or revenue sharing. Treating just 1 patient each
                                        • Clearing of stubborn psoriatic lesions occurs rapidly
                                                                                                                    month generally covers your lease. Treating just 4 patients each
                                           and safely.2
                                                                                                                    month means less than a 1-year payback period.
                                        • After 2 to 4 weeks of thrice weekly treatments, the degree of
                                           vitiligo repigmentation is higher than with any other therapy.3
                                        • Slightly more than 50% of the vitiligo patients showed
are state-of-the-art UVB lasers            75% or more pigmentation after 30 treatments or less.4

that treat psoriasis and vitiligo
more effectively, safely, and
conveniently than topical
                                    Bónis et al. 308-nm UVB excimer laser for psoriasis. The Lancet.                Gerber et al. Ultraviolet B 308-nm excimer laser treatment of psoriasis: a
treatments or lamp phototherapy.    1997;350:1522.                                                                  new phototherapeutic approach. British Journal of Dermatology.
                                                                                                                    2003;149:1250-1258.
                                    Asawanonda et al. 308-nm Excimer Laser for the Treatment of Psoriasis:
                                    A Dose-Response Study. Archives of Dermatology. 2000;136:619-24.                Taneja et al. 308-nm Excimer Laser for the Treatment of Psoriasis:
Patients benefit from targeted                                                                                      Induration-Based Dosimetry. Archives of Dermatology. 2003;139:759-64.2
                                    Novak et al. Xenon Chloride Ultraviolet B Laser is More Effective in Treating
                                                                                                                    Taylor et al. A 308-nm Excimer Laser for the Treatment of Scalp Psoriasis.
monochromatic 308-nm UVB            Psoriasis and in inducing T Cell Apoptosis than Narrow-band Ultraviolet B.
                                    Journal of Photochemistry and Photobiology. 2002;67:32-8.                       Lasers in Surgery and Medicine. 2004;34:136-140.

phototherapy for fast clearing      Feldman et al. Efficacy of the 308-nm Excimer Laser for Treatment of
                                    Psoriasis: Results of a Multicenter Study. Journal of the American Academy
                                    of Dermatology. 2002;46(6):900-6.11
and long remission.
                                    Mafong et al. Treatment of Inverse Psoriasis with the 308-nm Excimer Laser.     Spencer et al. Treatment of Vitiligo with the 308-nm Excimer Laser:
                                    Dermatology Surgery. 2002;28(6):530-2.                                          A Pilot Study. Journal of the American Academy of Dermatology.
                                                                                                                    2002;46(5):727-31.3
Your practice profits from          Trehan et al. Medium-dose 308-nm Excimer Laser for the Treatment of
                                    Psoriasis. Journal of the American Academy of Dermatology.                      Baltás et al. Treatment of Vitiligo with the 308-nm Xenon Chloride
widespread reimbursement,           2002;47(5):701-8.                                                               Excimer Laser. Archives of Dermatology. 2002;138:1619-20.

                                    Trehan et al. High-dose 308-nm Excimer Laser for the Treatment of Psoriasis.    Taneja et al. 308-nm Excimer Laser for the Treatment of Localized Vitiligo.
recurring revenue, and high         Journal of the American Academy of Dermatology. 2002;46(5):732-7   .            International Journal of Dermatology. 2003;42:658-62.

                                    Housman et al. A maintenance protocol for psoriasis plaques cleared by the      Hadi et al. The Use of the 308-nm Excimer Laser for the Treatment of
return on investment.               308-nm excimer laser. Journal of Dermatological Treatment. 2003;94-97 .         Vitiligo. Dermatologic Surgery. 2004;30(7):983-6.4

				
DOCUMENT INFO